MARÍA ESPERANZA
HERREROS AVILÉS
Profesora asociada
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (8)
2021
-
A novel class of fast-acting antimalarial agents: Substituted 15-membered azalides
British Journal of Pharmacology, Vol. 178, Núm. 2, pp. 363-377
2012
-
Design, synthesis, and in vitro activity of novel 2′- O -substituted 15-membered azalides
Journal of Medicinal Chemistry, Vol. 55, Núm. 7, pp. 3216-3227
-
Novel hybrid molecules based on 15-membered azalide as potential antimalarial agents
European Journal of Medicinal Chemistry, Vol. 49, pp. 365-378
2011
-
Four year immunogenicity of the RTS,S/AS02 A malaria vaccine in Mozambican children during a phase IIb trial
Vaccine, Vol. 29, Núm. 35, pp. 6059-6067
2008
-
Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials
Journal of Medicinal Chemistry, Vol. 51, Núm. 9, pp. 2845-2852
2007
-
Evaluation of N-(phenylmethyl)-4-[5-(phenylmethyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-4-yl]benzamide inhibitors of Mycobacterium tuberculosis growth
Bioorganic and Medicinal Chemistry Letters, Vol. 17, Núm. 10, pp. 2740-2744
2001
1997
-
Microplate assays for in vitro evaluation of anti-Pneumocystis drugs
Journal of Eukaryotic Microbiology